SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-020705
Filing Date
2017-04-17
Accepted
2017-04-17 16:09:34
Documents
48
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v463352_10q.htm 10-Q 234454
2 EXHIBIT 31.1 v463352_ex31-1.htm EX-31.1 10854
3 EXHIBIT 31.2 v463352_ex31-2.htm EX-31.2 10811
4 EXHIBIT 32.1 v463352_ex32-1.htm EX-32.1 4912
5 EXHIBIT 32.2 v463352_ex32-2.htm EX-32.2 4883
  Complete submission text file 0001144204-17-020705.txt   1871723

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dprx-20170331.xml EX-101.INS 275010
7 XBRL TAXONOMY EXTENSION SCHEMA dprx-20170331.xsd EX-101.SCH 24355
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dprx-20170331_cal.xml EX-101.CAL 23498
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dprx-20170331_def.xml EX-101.DEF 129546
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dprx-20170331_lab.xml EX-101.LAB 197692
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dprx-20170331_pre.xml EX-101.PRE 162665
Mailing Address 14 WALL ST. SUITE 3D NEW YORK NY 10005
Business Address 14 WALL ST. SUITE 3D NEW YORK NY 10005 212-269-2834
Dipexium Pharmaceuticals, Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36351 | Film No.: 17764660
SIC: 2834 Pharmaceutical Preparations